Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 35% ± 10% | |
lung | 17 studies | 37% ± 13% | |
intestine | 12 studies | 34% ± 9% | |
kidney | 8 studies | 45% ± 14% | |
brain | 8 studies | 29% ± 12% | |
liver | 8 studies | 38% ± 12% | |
eye | 6 studies | 27% ± 12% | |
uterus | 6 studies | 44% ± 14% | |
lymph node | 5 studies | 34% ± 8% | |
pancreas | 4 studies | 43% ± 16% | |
bone marrow | 4 studies | 30% ± 12% | |
skin | 4 studies | 32% ± 8% | |
breast | 4 studies | 31% ± 11% | |
ovary | 3 studies | 37% ± 7% | |
heart | 3 studies | 20% ± 6% | |
adrenal gland | 3 studies | 43% ± 7% | |
placenta | 3 studies | 36% ± 7% | |
prostate | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 6066.63 | 652 / 653 | 99% | 303.45 | 597 / 605 |
liver | 100% | 17487.20 | 226 / 226 | 99% | 189.19 | 400 / 406 |
breast | 99% | 5027.29 | 456 / 459 | 98% | 109.74 | 1092 / 1118 |
intestine | 100% | 6741.18 | 966 / 966 | 96% | 109.20 | 508 / 527 |
brain | 94% | 3644.58 | 2484 / 2642 | 100% | 291.44 | 705 / 705 |
kidney | 100% | 5867.91 | 89 / 89 | 94% | 191.02 | 845 / 901 |
prostate | 100% | 4900.35 | 244 / 245 | 92% | 97.01 | 461 / 502 |
stomach | 91% | 2857.15 | 327 / 359 | 98% | 103.72 | 279 / 286 |
ovary | 100% | 11253.49 | 180 / 180 | 86% | 66.12 | 369 / 430 |
lung | 99% | 6298.74 | 573 / 578 | 83% | 62.82 | 961 / 1155 |
adrenal gland | 100% | 7039.84 | 258 / 258 | 80% | 93.46 | 184 / 230 |
uterus | 98% | 4108.79 | 166 / 170 | 81% | 88.72 | 374 / 459 |
pancreas | 80% | 1764.06 | 261 / 328 | 96% | 79.41 | 171 / 178 |
bladder | 100% | 6457.05 | 21 / 21 | 75% | 75.82 | 377 / 504 |
esophagus | 83% | 3592.71 | 1201 / 1445 | 69% | 53.55 | 127 / 183 |
skin | 94% | 3383.12 | 1698 / 1809 | 56% | 35.95 | 265 / 472 |
blood vessel | 100% | 25245.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 4913.24 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 6799.21 | 1197 / 1204 | 0% | 0 | 0 / 0 |
heart | 90% | 4504.01 | 778 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 86% | 2916.02 | 801 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 80.46 | 37 / 45 |
lymph node | 0% | 0 | 0 / 0 | 79% | 66.01 | 23 / 29 |
eye | 0% | 0 | 0 / 0 | 56% | 45.63 | 45 / 80 |
muscle | 10% | 158.68 | 80 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000177 | Biological process | regulation of neural precursor cell proliferation |
GO_0045664 | Biological process | regulation of neuron differentiation |
GO_0045651 | Biological process | positive regulation of macrophage differentiation |
GO_0045777 | Biological process | positive regulation of blood pressure |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0033598 | Biological process | mammary gland epithelial cell proliferation |
GO_0007507 | Biological process | heart development |
GO_0048663 | Biological process | neuron fate commitment |
GO_0045475 | Biological process | locomotor rhythm |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0061031 | Biological process | endodermal digestive tract morphogenesis |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0048711 | Biological process | positive regulation of astrocyte differentiation |
GO_0051148 | Biological process | negative regulation of muscle cell differentiation |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_0019216 | Biological process | regulation of lipid metabolic process |
GO_0060749 | Biological process | mammary gland alveolus development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0061030 | Biological process | epithelial cell differentiation involved in mammary gland alveolus development |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0021772 | Biological process | olfactory bulb development |
GO_0007623 | Biological process | circadian rhythm |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030154 | Biological process | cell differentiation |
GO_0048557 | Biological process | embryonic digestive tract morphogenesis |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_0090398 | Biological process | cellular senescence |
GO_0043353 | Biological process | enucleate erythrocyte differentiation |
GO_0003166 | Biological process | bundle of His development |
GO_0045578 | Biological process | negative regulation of B cell differentiation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0000791 | Cellular component | euchromatin |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0140110 | Molecular function | transcription regulator activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ID2 |
Protein name | DNA-binding protein inhibitor ID-2 (Inhibitor of DNA binding 2) (Inhibitor of differentiation 2) DNA-binding protein inhibitor ID-2 (Class B basic helix-loop-helix protein 26) (bHLHb26) (Inhibitor of DNA binding 2) (Inhibitor of differentiation 2) |
Synonyms | hCG_1784377 BHLHB26 GIG8 |
Description | FUNCTION: Transcriptional regulator (lacking a basic DNA binding domain) which negatively regulates the basic helix-loop-helix (bHLH) transcription factors by forming heterodimers and inhibiting their DNA binding and transcriptional activity. Implicated in regulating a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation. Inhibits skeletal muscle and cardiac myocyte differentiation. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer. Restricts the CLOCK and BMAL1 localization to the cytoplasm. Plays a role in both the input and output pathways of the circadian clock: in the input component, is involved in modulating the magnitude of photic entrainment and in the output component, contributes to the regulation of a variety of liver clock-controlled genes involved in lipid metabolism. . FUNCTION: Transcriptional regulator (lacking a basic DNA binding domain) which negatively regulates the basic helix-loop-helix (bHLH) transcription factors by forming heterodimers and inhibiting their DNA binding and transcriptional activity. Implicated in regulating a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation. Inhibits skeletal muscle and cardiac myocyte differentiation. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer. Restricts the CLOCK and BMAL1 localization to the cytoplasm. Plays a role in both the input and output pathways of the circadian clock: in the input component, is involved in modulating the magnitude of photic entrainment and in the output component, contributes to the regulation of a variety of liver clock-controlled genes involved in lipid metabolism. . |
Accessions | ENST00000396290.2 Q02363 Q53T66 ENST00000234091.8 ENST00000331129.3 |